Reuters, 1st, Russian state financial supporters revealed that Russia will start to implement its first approved antiviral drug to treat patients infected with Covid-19 next week, which is called "game changer", and it is reported that it can speed up the recovery of normal economic life in Russia.

in an interview with Reuters, the head of the sovereign wealth fund of the Russian direct investment fund (RDIF) said that Russian hospitals can provide this drug to patients from June 11th, which is enough to treat about 6, people every month.

At present, there is no approved vaccine for Covid-19 in the world, and the global scientific community has not yet reached a consensus on the efficacy of Russian improved antiviral drugs.

On May 31st, the first Russian drug "Avifavir" used to fight Covid-19 was approved by the Russian Ministry of Health. On the same day, Russian Health Minister Murashko announced that the vaccine developed by Russia will begin clinical trials in about two weeks.

Kirill Dmitriev, head of the Russian direct investment foundation, said that the clinical trial involved 33 people and showed that the drug could successfully treat the virus within four days in most cases.

He said that the clinical trial is scheduled to end in about a week, and more clinical trials will be conducted. He added that the Ministry of Health has approved? The use of this drug in the special acceleration process was approved and production began in March.